Rapport Therapeutics Cash Flow Statement (2023-2026) | RAPP

Cash Flow Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -6.41M-8.71M-13.52M-15.28M-18.12M-17.54M-19.98M-24.06M-26.73M-26.93M-33.76M-19.86M
Depreciation and Depletion (Quarter) 0.10M0.02M0.04M0.20M0.20M0.20M0.20M0.20M0.30M0.30M0.20M0.20M
Share-based Compensation (Quarter) 0.94M0.86M1.00M1.49M2.35M3.18M3.21M4.04M4.39M4.74M-12.26M6.96M
Gains from Sales and Divestitures (Quarter) 0.10M0.47M0.61M0.05M0.26M0.39M0.03M0.09M
Gains from Investment Securities (Quarter) 1.38M0.10M1.63M6.12M6.30M
Non-cash Items (Quarter) 6.25M56.01M44.98M34.32M0.91M16.37M112.36M113.84M2.46M
Cash from Operations (Quarter) -5.42M-10.36M-17.61M-16.35M-16.41M-14.45M-20.24M-25.07M-17.46M-24.70M-13.06M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.02M0.16M1.65M-1.33M0.17M0.41M0.12M-0.20M1.07M0.36M
Depreciation & Amortization (CF) (Quarter) 0.10M0.02M0.05M0.15M0.21M0.22M0.26M0.24M0.25M0.26M0.27M0.23M
Change in Working Capital
Change in Receivables (Quarter) 0.06M
Change in Account Payables (Quarter) 0.63M0.72M-1.13M0.09M0.05M0.65M0.18M1.03M-0.18M1.18M2.31M
Change in Accured Expenses (Quarter) 1.10M3.38M0.18M-0.98M0.32M0.85M0.33M0.45M1.70M3.69M-3.49M
Investing Activities
Capital Expenditures (Quarter) 0.05M1.44M1.07M0.97M0.14M0.23M0.29M0.02M0.13M0.17M0.09M
Change in Acquisitions & Divestments (Quarter) 3.95M32.29M56.84M116.72M100.03M44.98M22.92M10.07M
Cash from Investing Activities (Quarter) -0.05M-78.66M-41.93M-107.10M-53.04M31.93M21.03M22.60M-56.78M-174.32M37.94M
Financing Activities
Other financing activities (Quarter) -0.03M0.09M15.50M0.06M0.27M
Change in Capital Stock
Shares Issued (Quarter) -1.39M0.01M0.64M0.71M0.81M
Preferred Shares Issued (Quarter) 25.39M-21.39M64.00M-0.09M
Misc.
Cash from Financing Activities (Quarter) 85.36M-0.14M63.66M159.35M-1.39M0.01M0.01M-0.06M270.53M0.31M0.53M
Change in Cash (Quarter) 79.88M-89.16M4.12M35.90M-70.85M17.49M0.80M-2.54M196.29M-198.71M25.41M
Free Cash Flow (Quarter) -5.48M-11.79M-18.69M-17.32M-16.55M-14.67M-20.53M-25.09M-17.60M-24.87M-13.15M
Net Cash Flow (Quarter) 79.88M-89.16M4.12M35.90M-70.85M17.49M0.80M-2.54M196.29M-198.71M25.41M